AUGDIMER, LLC

Medtech

Provoked D-Dimer (PDD) assay—an improved blood test for venous thromboembolism that adds thrombolytics in vitro to enhance specificity and positive predictive value over standard D-Dimer testing

Grants
$149K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · The Diagnostic Utility of the in-vitro "Provoked" D dimer test in patients with suspected pulmonary embolism$148,864
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1002Lumafield——
1003Cam2Technologies, LLC——
1004DrinkSavvy, Inc.——
1005AUGDIMER, LLC——
1006LifeAire Systems, LLC—$2.3M
1007NVIZIX LLC——
1008Nervana Systems, Inc.—$24M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.